On ECHEMI
Home > Drugs > Shanghai Xinke Pharmaceutical Co., Ltd.
Shanghai Xinke Pharmaceutical Co., Ltd.
  • Founded in:

    1993-10-07
  • Country:

    China China
  • Address:

    No. 528, Chundong Road, Xinzhuang Industrial Zone, Minhang District, Shanghai
  • Tax NO.:

    91310000607269583X
  • Registered Funds:

    $1.53 million
  • Website:

  • Email:

Related Drugs
Technetium [99mTc] ethyl cysteate injection
Name Description Content CAS NO. Registered Holders
Technetium [99mTc] diethyl cysteate

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Technetium [99mTc] ethyl cysteate injection
Name Description Content CAS NO. Registered Holders
Technetium [99mTc] diethyl cysteate

0
Technetium [99mTc] ethyl cysteate injection
Name Description Content CAS NO. Registered Holders
Technetium [99mTc] diethyl cysteate

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Technetium [99mTc] Methylene Diphosphonate Injection
Methylene diphosphonates.
Name Description Content CAS NO. Registered Holders
Hydroxymethylene diphosphonate Radiochemical Purity Test EP Standard

It has anti-inflammatory and analgesic effects in rat and mouse animal models, and has preventive and therapeutic effects on rat adjuvant arthritis model

More

It has anti-inflammatory and analgesic effects in rat and mouse animal models, and has preventive and therapeutic effects on rat adjuvant arthritis model

0
Technetium [99mTc] Bicysteine Injection
The main ingredient of this product and its chemical name are: pertechnetium [99mTc] acid dicysteine.
Name Description Content CAS NO. Registered Holders
Pertechnetium [99mTc] acid bis-cysteine

After intravenous injection, this product has a high first-pass clearance rate in the kidney and can quickly accumulate in the kidney, which is 6.6 times and 2.4 times the radioactivity in the liver and blood, respectively. Therefore, it can be used to detect changes in local renal blood perfusion.

More

After intravenous injection, this product has a high first-pass clearance rate in the kidney and can quickly accumulate in the kidney, which is 6.6 times and 2.4 times the radioactivity in the liver and blood, respectively. Therefore, it can be used to detect changes in local renal blood perfusion.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.